Avenue Therapeutics, Inc.

BST:49Y0 Stock Report

Market Cap: €3.4m

Avenue Therapeutics Balance Sheet Health

Financial Health criteria checks 4/6

Avenue Therapeutics has a total shareholder equity of $654.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.9M and $1.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$1.78m
EquityUS$654.00k
Total liabilitiesUS$1.20m
Total assetsUS$1.85m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 49Y0's short term assets ($1.9M) exceed its short term liabilities ($1.2M).

Long Term Liabilities: 49Y0 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 49Y0 is debt free.

Reducing Debt: 49Y0 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 49Y0 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 49Y0 has less than a year of cash runway if free cash flow continues to grow at historical rates of 16.9% each year.


Discover healthy companies